Skip to content

Diet and Exercise Frailty Intervention in Cardiac Device Patients

Diet and Exercise Frailty Intervention in Cardiac Device Patients Trial Pilot

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04052672
Acronym
DEFINIT-P
Enrollment
0
Registered
2019-08-12
Start date
2019-11-01
Completion date
2020-12-30
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Frailty

Keywords

Exercise, Nutritional Supplement, Physical Function, Quality of Life, Cardiac Device, Physical Activity, Defibrillators, Pacemakers, Biomarkers

Brief summary

DEFINIT-P is a prospective pilot study of frailty in cardiac device recipients, comprised of a registry and randomized control trial. The RCT is a supervised exercise program and nutritional supplement intervention for pre-frail and frail cardiac device participants. The registry will be used to describe all cardiac device recipients, regardless of frailty status.

Detailed description

DEFINIT-P is a single center randomized controlled trial and registry. This pilot study will determine the feasibility of a larger, multi-center randomized clinical trial which aims to evaluate the efficacy of a supervised exercise program and nutritional supplement program in reversing or preventing progression of frailty in cardiac device recipients. The future trial would also examine the physiologic effects of exercise and nutritional supplementation to understand their effects on blood biomarker profiles, which will provide insight into potentially targetable mechanisms underlying frailty.

Interventions

OTHERExercise and Nutritional Supplement

The intervention consists of exercise (a combination of supervised and in home) as well as a nutritional supplement (a combination of whey protein and creatine).

Sponsors

Population Health Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Permanent pacemaker recipients OR 2. Implantable cardioverter defibrillator recipients

Exclusion criteria

1. Age \<55 years, or 2. Unwilling to consent Patients will be eligible for the registry but not eligible for the randomized control trial if they fulfill any of: 1. Are non-frail 2. Already undertaking \>1 hour per week of dedicated exercise 3. Existing or prior referral for cardiac rehabilitation 4. Moderate or severe heart failure (New York Heart Association class III or IV) 5. Unstable angina 6. Any other medical condition that will prevent exercise participation 7. Dementia, as identified by a Mini-Mental State Examination score \<25

Design outcomes

Primary

MeasureTime frameDescription
Rate of identification of eligible patients1 yearThe primary outcome will be the number of patients that meet eligibility criteria.
The proportion of eligible patients consenting to participate and randomized1 yearThe number of eligible patients that agree to participate in the randomized control trial and the number of eligible patients that consent to participate in the observational trial
The change in the rate of adherence to the trial interventions from baseline to 12 months3 months, 6 months, 1 yearThe intervention adherence of both the exercise intervention and nutritional supplement
Barriers and facilitators of adherence to the intervention1 yearThe identification of barriers to exercise and nutritional supplement adherence

Secondary

MeasureTime frameDescription
Frailty biomarker levels1 yearThe change in frailty biomarkers (not yet determined) from baseline to 12 months
Injury from a fall or fractures1 yearThe rate of occurrence of injury from a fall or fracture
Physical activity levels as measured by the cardiac device (Permanent pacemaker or Implantable cardioverter defibrillator)1 yearThe change in the volume of physical activity as detected by device (hours per day)
Myocardial infarction, stroke, heart failure hospitalization, atrial fibrillation or ventricular tachyarrhythmia1 yearThe rate of occurrence of myocardial infarction, stroke, heart failure hospitalization, atrial fibrillation or ventricular tachyarrhythmia
Cardiac device complications1 yearThe rate of occurrence of inappropriate defibrillator shocks or lead dislodgement

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026